TY - JOUR
T1 - Physiological growth of ocular axial length among Chinese children and teenagers: A 6-year cohort study
AU - Chen, Yanxian
AU - Ding, Xiaohu
AU - Xiong, Ruilin
AU - Zhang, Jian
AU - Song, Fan
AU - Zhao, Ziwei
AU - Lai, Mengying
AU - Zeng, Yangfa
AU - He, Mingguang
N1 - Publisher Copyright:
© 2025 Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2025/1/24
Y1 - 2025/1/24
N2 - To investigate the pattern and threshold of physiological growth, defining as axial length (AL) elongation that results in little refraction progression, among Chinese children and teenagers, a total of 916 children aged between 7 and 18 years from a 6-year longitudinal cohort study were included for analysis. Ocular biometry, cycloplegic refraction and demographic data were obtained annually. Physiological growth was calculated based on myopic progression and Gullstrand eye model, respectively. The annual change in AL was found to be significantly smaller in the persistent emmetropia (PE) group compared to the incident myopia (IM) and persistent myopia (PM) group at all ages (all P < 0.05). In children with non-progressive myopia, there was observed axial elongation ranging from 0.17 to 0.23 mm/year between the ages of 9 and 12. This growth rate persisted at approximately 0.10 mm/year beyond the age of 12. While the compensated AL growth calculated using Gullstrand model was only 0.02 to 0.15 mm/year at age of 9–12, and decreased to around 0 mm/year after age of 12. For children aged 7–9 years, the cutoff point for AL growth to distinguish between progressive myopia and non-progressive myopia was 0.19 mm/year. These findings indicate a notable disparity between the thresholds of physiological growth calculated using myopic progression and Gullstrand eye model. This observation suggests that when formulating effective myopia control strategies, consideration should be given to different calculation methods when applying physiological AL growth as a starting point or target.
AB - To investigate the pattern and threshold of physiological growth, defining as axial length (AL) elongation that results in little refraction progression, among Chinese children and teenagers, a total of 916 children aged between 7 and 18 years from a 6-year longitudinal cohort study were included for analysis. Ocular biometry, cycloplegic refraction and demographic data were obtained annually. Physiological growth was calculated based on myopic progression and Gullstrand eye model, respectively. The annual change in AL was found to be significantly smaller in the persistent emmetropia (PE) group compared to the incident myopia (IM) and persistent myopia (PM) group at all ages (all P < 0.05). In children with non-progressive myopia, there was observed axial elongation ranging from 0.17 to 0.23 mm/year between the ages of 9 and 12. This growth rate persisted at approximately 0.10 mm/year beyond the age of 12. While the compensated AL growth calculated using Gullstrand model was only 0.02 to 0.15 mm/year at age of 9–12, and decreased to around 0 mm/year after age of 12. For children aged 7–9 years, the cutoff point for AL growth to distinguish between progressive myopia and non-progressive myopia was 0.19 mm/year. These findings indicate a notable disparity between the thresholds of physiological growth calculated using myopic progression and Gullstrand eye model. This observation suggests that when formulating effective myopia control strategies, consideration should be given to different calculation methods when applying physiological AL growth as a starting point or target.
UR - http://www.scopus.com/inward/record.url?scp=85216403485&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0317756
DO - 10.1371/journal.pone.0317756
M3 - Journal article
C2 - 39854571
AN - SCOPUS:85216403485
SN - 1932-6203
VL - 20
SP - 1
EP - 11
JO - PLoS ONE
JF - PLoS ONE
IS - 1
M1 - e0317756
ER -